BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36167912)

  • 1. Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration.
    Nopia H; Kurimoto D; Sato A
    Biometals; 2023 Jun; 36(3):629-638. PubMed ID: 36167912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin fusion at the N-terminus or C-terminus of human lactoferrin leads to improved pharmacokinetics and anti-proliferative effects on cancer cell lines.
    Ueda K; Shimizu M; Ohashi A; Murata D; Suzuki T; Kobayashi N; Baba J; Takeuchi T; Shiga Y; Nakamura M; Kagaya S; Sato A
    Eur J Pharm Sci; 2020 Dec; 155():105551. PubMed ID: 32946958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellularly delivered human lactoferrin functions as an activator of Na
    Kurimoto D; Hue Anh TD; Kasama R; Sato A
    Biochem Biophys Res Commun; 2024 Feb; 695():149480. PubMed ID: 38215552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced intracellular uptake of an albumin fusion protein in cancer cells by its forced cell surface recruitment.
    Kurimoto D; Sato A
    Eur J Pharm Sci; 2023 Dec; 191():106591. PubMed ID: 37742986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human lactoferrin-Fc fusion with an improved plasma half-life.
    Shiga Y; Oshima Y; Kojima Y; Sugimoto A; Tamaki N; Murata D; Takeuchi T; Sato A
    Eur J Pharm Sci; 2015 Jan; 67():136-143. PubMed ID: 25433245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hinge-Deficient IgG1 Fc Fusion: Application to Human Lactoferrin.
    Shiga Y; Murata D; Sugimoto A; Oshima Y; Tada M; Ishii-Watabe A; Imai K; Tomii K; Takeuchi T; Kagaya S; Sato A
    Mol Pharm; 2017 Sep; 14(9):3025-3035. PubMed ID: 28763236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP-2 fusion protein with human serum albumin potentiates anti-angiogenesis-mediated inhibition of tumor growth by suppressing MMP-2 expression.
    Lee MS; Jung JI; Kwon SH; Lee SM; Morita K; Her S
    PLoS One; 2012; 7(4):e35710. PubMed ID: 22545131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effect of human lactoferrin on glioblastoma growth.
    Arcella A; Oliva MA; Staffieri S; Aalberti S; Grillea G; Madonna M; Bartolo M; Pavone L; Giangaspero F; Cantore G; Frati A
    J Neurosurg; 2015 Oct; 123(4):1026-35. PubMed ID: 26186026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic effect of human lactoferrin against Streptococcus mutans bacteremia in lactoferrin knockout mice.
    Velusamy SK; Fine DH; Velliyagounder K
    Microbes Infect; 2014 Sep; 16(9):762-7. PubMed ID: 25124544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effects of human lactoferrin during Aggregatibacter actinomycetemcomitans-induced bacteremia in lactoferrin-deficient mice.
    Velusamy SK; Poojary R; Ardeshna R; Alabdulmohsen W; Fine DH; Velliyagounder K
    Antimicrob Agents Chemother; 2014; 58(1):397-404. PubMed ID: 24189260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa-miR-623 suppresses tumor progression in human lung adenocarcinoma.
    Wei S; Zhang ZY; Fu SL; Xie JG; Liu XS; Xu YJ; Zhao JP; Xiong WN
    Cell Death Dis; 2016 Sep; 7(9):e2388. PubMed ID: 27685632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Proliferative Effect of Human Lactoferrin and Its Proteolytic Peptide on Normal and Transformed Epithelial Cells.
    Hwang SM; Chung IY; Jo JH; Yoon TJ; Lee HH
    Appl Biochem Biotechnol; 2016 Jan; 178(1):44-57. PubMed ID: 26400493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression effects of recombinant adenovirus expressing human lactoferrin on cervical cancer in vitro and in vivo.
    Li WY; Li QW; Han ZS; Jiang ZL; Yang H; Li J; Zhang XB
    Cancer Biother Radiopharm; 2011 Aug; 26(4):477-83. PubMed ID: 21834714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA hsa-miR-623 directly suppresses MMP1 and attenuates IL-8-induced metastasis in pancreatic cancer.
    Chen Y; Peng S; Cen H; Lin Y; Huang C; Chen Y; Shan H; Su Y; Zeng L
    Int J Oncol; 2019 Jul; 55(1):142-156. PubMed ID: 31115512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Endocytosis of the Human Lactoferrin N-Lobe Enhances Its Antiproliferative Activity against Human Cancer Cells.
    Nakamura M; Shiga A; Iimori A; Matsuzaki T
    Biol Pharm Bull; 2023 Jul; 46(7):1004-1009. PubMed ID: 37088555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface display of human lactoferrin using a glycosylphosphatidylinositol-anchored protein of Saccharomyces cerevisiae in Pichia pastoris.
    Jo JH; Im EM; Kim SH; Lee HH
    Biotechnol Lett; 2011 Jun; 33(6):1113-20. PubMed ID: 21267758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. hsa_circRNA_001587 upregulates SLC4A4 expression to inhibit migration, invasion, and angiogenesis of pancreatic cancer cells via binding to microRNA-223.
    Zhang X; Tan P; Zhuang Y; Du L
    Am J Physiol Gastrointest Liver Physiol; 2020 Dec; 319(6):G703-G717. PubMed ID: 32878470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein.
    Picard-Jean F; Bouchard S; Larivée G; Bisaillon M
    Antiviral Res; 2014 Nov; 111():13-22. PubMed ID: 25193851
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.